FI913350A0 - Mot bordetella pertussis verksamma vacciner, vilka aer sammansatta av individuellt renade pertussis-antigener. - Google Patents
Mot bordetella pertussis verksamma vacciner, vilka aer sammansatta av individuellt renade pertussis-antigener.Info
- Publication number
- FI913350A0 FI913350A0 FI913350A FI913350A FI913350A0 FI 913350 A0 FI913350 A0 FI 913350A0 FI 913350 A FI913350 A FI 913350A FI 913350 A FI913350 A FI 913350A FI 913350 A0 FI913350 A0 FI 913350A0
- Authority
- FI
- Finland
- Prior art keywords
- pertussis
- vacciner
- sammansatta
- renade
- individuellt
- Prior art date
Links
- 241000588832 Bordetella pertussis Species 0.000 title 1
- 201000005702 Pertussis Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54923690A | 1990-07-11 | 1990-07-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI913350A0 true FI913350A0 (fi) | 1991-07-10 |
FI913350A FI913350A (fi) | 1992-01-12 |
Family
ID=24192174
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI913350A FI913350A (fi) | 1990-07-11 | 1991-07-10 | Mot bordetella pertussis verksamma vacciner, vilka aer sammansatta av individuellt renade pertussis-antigener. |
Country Status (10)
Country | Link |
---|---|
US (4) | US5885586A (fi) |
EP (1) | EP0484621A3 (fi) |
JP (1) | JPH04230328A (fi) |
KR (1) | KR920002790A (fi) |
AU (1) | AU8033591A (fi) |
CA (1) | CA2046543A1 (fi) |
FI (1) | FI913350A (fi) |
IL (1) | IL98233A0 (fi) |
NO (1) | NO912713L (fi) |
PT (1) | PT98257A (fi) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8412207D0 (en) | 1984-05-12 | 1984-06-20 | Wellcome Found | Antigenic preparations |
GB8910570D0 (en) | 1989-05-08 | 1989-06-21 | Wellcome Found | Acellular vaccine |
US5156958A (en) * | 1990-09-21 | 1992-10-20 | American Cyanamid Company | Gene encoding a 30 kilodalton outer membrane protein of bordetella pertussis and method of recombinant production of said protein |
US6444211B2 (en) * | 1991-04-03 | 2002-09-03 | Connaught Laboratories, Inc. | Purification of a pertussis outer membrane protein |
GB9209118D0 (en) * | 1992-04-28 | 1992-06-10 | Sb 120 Amsterdam Bv | Vaccine compositions |
AU7788194A (en) | 1993-10-05 | 1995-05-01 | Medeva Holdings B.V. | Vaccine compositions |
CA2188424A1 (en) * | 1994-04-28 | 1995-11-09 | Akihiro Suehara | Method of separating protective components of bordetella pertussis |
NZ306392A (en) * | 1995-05-04 | 1999-04-29 | Connaught Lab | Acellular pertussisvaccines, fimbrial agglutinogin preparation prepared from bordetella strain preparation |
US20030157129A1 (en) * | 1995-06-23 | 2003-08-21 | Smithkline Beecham Biologicals S.A. | Vaccine comprising a polysaccharide antigen - carrier protein conjugate and free carrier protein |
US20020054884A1 (en) | 1995-06-23 | 2002-05-09 | Smithkline Beecham Biologicals, Sa | Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
GB9611501D0 (en) * | 1996-06-03 | 1996-08-07 | Smithkline Beecham Biolog | Vaccine compositions |
SK283565B6 (sk) | 1996-07-02 | 2003-09-11 | Connaught Laboratories Limited | Multivalentná imunogénna kompozícia a jej použitie |
US20010014331A1 (en) * | 1996-11-07 | 2001-08-16 | Smithkline Beecham Biologicals S.A. | Acellular pertussis vaccine with diphthriae-and tetanus-toxoids |
US7087236B1 (en) | 1998-09-01 | 2006-08-08 | Merrion Research I Limited | Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof |
US7172762B1 (en) * | 1999-01-29 | 2007-02-06 | Pfizer Inc. | Erysipelothrix rhusiopathiae antigens and vaccine compositions |
US20020009466A1 (en) * | 1999-08-31 | 2002-01-24 | David J. Brayden | Oral vaccine compositions |
JP2001085516A (ja) * | 1999-09-10 | 2001-03-30 | Oki Electric Ind Co Ltd | 半導体装置の製造方法 |
GB9924351D0 (en) | 1999-10-14 | 1999-12-15 | Brennan Frank | Immunomodulation methods and compositions |
FR2809960B1 (fr) * | 2000-06-07 | 2004-04-23 | Pasteur Institut | Composition adjuvante de la reponse immunitaire comprenant la proteine fha ou un fragment de la proteine fha sous forme libre, et composition immunogene ou vaccinale contenant une telle composition adjuvante |
DK2116257T3 (da) * | 2000-08-09 | 2013-02-04 | Alk Abello As | Parenterale vaccineformuleringer og anvendelser deraf |
KR100401423B1 (ko) * | 2001-01-10 | 2003-10-17 | 주식회사 엘지생명과학 | 혼합 백신의 제조 방법 |
WO2003086204A2 (en) * | 2002-04-09 | 2003-10-23 | Neville Alleyne | Bone fixation apparatus |
ES2346314T3 (es) | 2003-10-02 | 2010-10-14 | Glaxosmithkline Biolog Sa | Antigenos de b. pertussis y uso de los mismos en vacunacion. |
US7578803B2 (en) * | 2004-03-18 | 2009-08-25 | C. R. Bard, Inc. | Multifunction adaptor for an open-ended catheter |
US20060115499A1 (en) * | 2004-09-27 | 2006-06-01 | Alk-Abello A/S | Liquid allergy vaccine formulation for oromucosal administration |
BRPI0519923A8 (pt) * | 2004-12-17 | 2018-01-23 | De Staat Der Nederlanden Vertegenwoordigd Door De Mini Van Vws | polipeptídeo, seqüência de dna, vetor de dna, anticorpo, bactéria, método para produzir lps parcialmente 3-0-desacilado, composição, usos da bactéria, e de lps de bordetella isolado compreendendo lps pelo menos parcialmente 3-0-desacilado, vacina, e, método in vitro para a desacilação de lps gram-negativo ou de composições compreendendo lps gram-negativo, e, para induzir uma resposta imune contra bordetella. |
WO2007111326A1 (ja) * | 2006-03-27 | 2007-10-04 | The Kitasato Institute | 長期保存においても毒性復帰がおこらない特徴を持つ全菌体細菌ワクチンならびにその用途 |
PL2066344T3 (pl) | 2006-09-07 | 2011-10-31 | Glaxosmithkline Biologicals Sa | Skojarzona szczepionka zawierająca inaktywowany wirus polio |
US20090093019A1 (en) * | 2007-04-27 | 2009-04-09 | Phelps Jamie P | Production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
KR100906369B1 (ko) | 2009-01-14 | 2009-07-06 | 김세영 | 수유 쿠션 |
SG11201506858SA (en) | 2013-03-08 | 2015-09-29 | Crucell Holland Bv | Acellular pertussis vaccine |
ES2929274T3 (es) | 2016-05-10 | 2022-11-28 | Najit Tech Inc | Inactivación de patógenos y producción de vacunas inactivadas altamente inmunógenas utilizando un proceso de oxidación dual |
WO2023043988A1 (en) * | 2021-09-17 | 2023-03-23 | Advanced Rx | Compositions, methods, systems and kits for the treatment of nosebleeds |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3043291A1 (de) * | 1980-11-17 | 1982-07-01 | Dso Pharmachim | Vakzine gegen keuchhusten |
CA1209036A (en) * | 1982-08-20 | 1986-08-05 | Joseph S.C. Kuo | Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine |
GB8412207D0 (en) * | 1984-05-12 | 1984-06-20 | Wellcome Found | Antigenic preparations |
FR2590483B1 (fr) * | 1985-11-22 | 1988-12-09 | Pasteur Institut | Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant |
GB8601279D0 (en) * | 1986-01-20 | 1986-02-26 | Public Health Lab Service | Purification of pertussis antigens |
FR2597344B1 (fr) * | 1986-04-16 | 1989-06-23 | Merieux Inst | Perfectionnement au procede de purification d'antigenes proteiques de bacteries appartenant au genre bordetella, en vue de l'obtention d'un vaccin acellulaire. |
GB8910570D0 (en) * | 1989-05-08 | 1989-06-21 | Wellcome Found | Acellular vaccine |
US5276142A (en) * | 1989-12-11 | 1994-01-04 | American Cyanamid Company | Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis |
US5578308A (en) * | 1990-02-12 | 1996-11-26 | Capiau; Carine | Glutaraldehyde and formalin detoxified bordetella toxin vaccine |
IT1248735B (it) * | 1990-06-21 | 1995-01-26 | Sclavo Spa | Vaccini acellulari contro la pertosse |
-
1991
- 1991-05-18 EP EP19910108108 patent/EP0484621A3/en not_active Withdrawn
- 1991-05-23 IL IL98233A patent/IL98233A0/xx unknown
- 1991-07-08 JP JP91192775A patent/JPH04230328A/ja active Pending
- 1991-07-09 CA CA002046543A patent/CA2046543A1/en not_active Abandoned
- 1991-07-09 PT PT98257A patent/PT98257A/pt not_active Application Discontinuation
- 1991-07-10 KR KR1019910011724A patent/KR920002790A/ko not_active Application Discontinuation
- 1991-07-10 NO NO91912713A patent/NO912713L/no unknown
- 1991-07-10 AU AU80335/91A patent/AU8033591A/en not_active Abandoned
- 1991-07-10 FI FI913350A patent/FI913350A/fi unknown
-
1995
- 1995-05-22 US US08/447,134 patent/US5885586A/en not_active Expired - Fee Related
- 1995-05-22 US US08/447,127 patent/US5895655A/en not_active Expired - Fee Related
- 1995-05-22 US US08/447,135 patent/US5885587A/en not_active Expired - Fee Related
- 1995-05-22 US US08/447,150 patent/US5897867A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FI913350A (fi) | 1992-01-12 |
US5897867A (en) | 1999-04-27 |
PT98257A (pt) | 1992-04-30 |
CA2046543A1 (en) | 1992-01-12 |
NO912713D0 (no) | 1991-07-10 |
IL98233A0 (en) | 1992-06-21 |
JPH04230328A (ja) | 1992-08-19 |
US5885587A (en) | 1999-03-23 |
AU8033591A (en) | 1992-01-16 |
NO912713L (no) | 1992-01-13 |
EP0484621A2 (en) | 1992-05-13 |
KR920002790A (ko) | 1992-02-28 |
US5895655A (en) | 1999-04-20 |
US5885586A (en) | 1999-03-23 |
EP0484621A3 (en) | 1992-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI913350A0 (fi) | Mot bordetella pertussis verksamma vacciner, vilka aer sammansatta av individuellt renade pertussis-antigener. | |
FI914512A (fi) | Foerfarande foer kontinuerlig produktion av tuggummi. | |
FI911422A (fi) | Anordning foer bruk av en svetseffektkaella foer matande av effekt till en plasmaskaerbraennare. | |
FI913678A (fi) | Anordning foer modulering av avsoekningshastigheten, vilken anordning aer foersedd med en spaerrkrets. | |
DE69113266D1 (de) | Adsorbentmittel. | |
FI915303A (fi) | Foerpackningspaose, isynnerhet av plastfolie. | |
DE69101015D1 (de) | Rotoren. | |
FI903073A0 (fi) | Anordning av kondensatsifon munstycke av roterande aongcylinder. | |
FI903035A (fi) | Foerfarande foer modifiering av olefinpolymerer till sammankopplingsmedel. | |
DE59104170D1 (de) | Angetriebene achse. | |
FI920058A0 (fi) | Foerfarande foer produktion av hirudiner och hirudin-liknande polypeptider med rekombinantteknologi. | |
FI87272B (fi) | Foerfarande foer kombinering av eluppvaermning till en murad vedeldad eldstad. | |
NO892997D0 (no) | Bordetella pertussis vaksine. | |
FI903414A (fi) | Produktion av proteiner i grampositiva bakterier. | |
FI915740A (fi) | Tobaksprodukt foer sjaelvframstaellning av en cigarrett, speciellt en filtercigarrett. | |
FI902968A (fi) | Siktenhet foer sortering av massor, saerskilt pappersmassa. | |
FI86278B (fi) | Kopplingsanordning foer koppling av en slaepvagn till en dragvagn. | |
FI920958A0 (fi) | Anordning foer breddstraeckning av loepande materialbanor, speciellt pappersbanor. | |
FI922586A (fi) | Tillvaext, produktion och samman- saettning av megakaryocyter och trombocyter. | |
FI900032A0 (fi) | Foerfarande och produktionsfaelt foer produktion av fraestorv. | |
FI904289A0 (fi) | Schack ii. | |
FI903848A0 (fi) | Foerfarande foer avlaegsning av halogenerade, organiska foereningar fraon avfallsvatten. | |
FI900568A0 (fi) | Foerfarande foer framstaellning av brand- och vaeder- bestaendiga traekompositer, speciellt byggnadskivor. | |
FI910452A0 (fi) | Foerfarande foer framstaellning av klinker. | |
ES1016120Y (es) | Hucha de juguete. |